LWLaura WatersMD, FRCPVideoHIVChinese HIV Clinical Forum Educational Series 2020 - 2021State of the Art: INSTI Toxicities and Their ManagementView Video
VideoHIVChinese HIV Clinical Forum Educational Series 2020 - 2021Roundtable Discussion: Strategies to Improve Drug Taking BehaviorView Video
CSWChen Seong WongMBBS, MRCP(UK), FAMSVideoHIVChinese HIV Clinical Forum Educational Series 2020 - 2021Switching ART to Improve Adherence: An Overview of Strategies - Chen Seong WongView Video
FVFrançois VenterMD, FCP, PhDSlidesetHIVChinese HIV Clinical Forum Educational Series 2020 - 2021Adherence Considerations in Choice of ARV Regimens - Francois VenterView Slideset
ACAndrea CalcagnoMD, DTM&HSlidesetHIVChinese HIV Clinical Forum Educational Series 2020 - 2021State of the Art: Clinical Pharmacology of INSTI - Andrea CalcagnoView Slideset
FVFrançois VenterMD, FCP, PhDVideoHIVChinese HIV Clinical Forum Educational Series 2020 - 2021Adherence Considerations in Choice of ARV Regimens - Francois VenterView Video
ACAndrea CalcagnoMD, DTM&HVideoHIVChinese HIV Clinical Forum Educational Series 2020 - 2021State of the Art: Clinical Pharmacology of INSTI - Andrea CalcagnoView Video
CYChia-Jui YangMDVideoHIVChinese HIV Clinical Forum Educational Series 2020 - 2021Recap the Second EditionView Video
KRKiat RuxrungthamMDSlidesetHIVChinese HIV Clinical Forum Educational Series 2020 - 2021HIV Drug Resistance in Asia Clinical Application - Kiat Ruxrungtham, MDView Slideset
CYChia-Jui YangMDSlidesetHIVChinese HIV Clinical Forum Educational Series 2020 - 2021Optimal use of DTG in treatment experienced patients - Chia-Jui YangView Slideset
AMAnne-Geneviève MarcelinMDSlidesetHIVChinese HIV Clinical Forum Educational Series 2020 - 2021State of the Art Resistance to INSTI - Anne - Geneviève MarcelinView Slideset
VideoHIVChinese HIV Clinical Forum Educational Series 2020 - 2021Roundtable Discussion: Resistance Considerations in Optimal Use of INSTIView Video
